[Federal Register Volume 84, Number 99 (Wednesday, May 22, 2019)]
[Notices]
[Pages 23581-23582]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10669]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of schedule I and schedule II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for a hearing were submitted for these notices.

[[Page 23582]]



----------------------------------------------------------------------------------------------------------------
                    Company                                FR docket                        Published
----------------------------------------------------------------------------------------------------------------
Meridian Medical Technologies.................  84 FR 7129.....................  March 1, 2019.
Organic Standards Solutions International, LLC  84 FR 13958....................  April 8, 2019.
SpecGx LLC....................................  84 FR 13954....................  April 8, 2019.
----------------------------------------------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I and II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each of the 
company's maintenance of effective controls against diversion by 
inspecting and testing each company's physical security systems, 
verifying each company's compliance with state and local laws, and 
reviewing each company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I and schedule II controlled substances to the 
above listed companies.

    Dated: May 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10669 Filed 5-21-19; 8:45 am]
 BILLING CODE 4410-09-P